These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND TFRC, P02786, 7037, ENSG00000072274, TFR1, CD71 AND Treatment
13 results:

  • 1. Feasibility of implementation of the early tumor shrinkage as a potential predictive marker to daily clinical practice in patients with RAS wild type metastatic colorectal cancer, treated with cetuximab - a non-interventional observational study.
    Fínek J; Vočka M; Bauer J; Kubala E; Zycháčková K; Šedivá M; Gharibyar M; Kocáková I; Čmuchařová E; Vaňková M
    Klin Onkol; 2024; 38(2):110-117. PubMed ID: 38697819
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. β-Lapachone induces ferroptosis of colorectal cancer cells via NCOA4-mediated ferritinophagy by activating JNK pathway.
    Zhao L; Miao H; Quan M; Wang S; Zhang Y; Zhou H; Zhang X; Lin Z; Piao J
    Chem Biol Interact; 2024 Feb; 389():110866. PubMed ID: 38218311
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The Role of Ferroptosis Signature in Overall Survival and Chemotherapy of Pancreatic Adenocarcinoma.
    Wei W; Hu Q; Li W; Li M; Dong S; Peng Y; Yin J; Lu Y; Liu L; Zhao Q
    DNA Cell Biol; 2022 Feb; 41(2):116-127. PubMed ID: 34898275
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Proteomics study of colorectal cancer and adenomatous polyps identifies tfr1, SAHH, and HV307 as potential biomarkers for screening.
    Tang M; Zeng L; Zeng Z; Liu J; Yuan J; Wu D; Lu Y; Zi J; Ye M
    J Proteomics; 2021 Jul; 243():104246. PubMed ID: 33915303
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunity.
    Hou Y; Liang HL; Yu X; Liu Z; Cao X; Rao E; Huang X; Wang L; Li L; Bugno J; Fu Y; Chmura SJ; Wu W; Luo SZ; Zheng W; Arina A; Jutzy J; McCall AR; Vokes EE; Pitroda SP; Fu YX; Weichselbaum RR
    Sci Transl Med; 2021 Feb; 13(582):. PubMed ID: 33627484
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. High activity and low toxicity of a novel cd71-targeting nanotherapeutic named The-0504 on preclinical models of several human aggressive tumors.
    Falvo E; Damiani V; Conti G; Boschi F; Messana K; Giacomini P; Milella M; De Laurenzi V; Morea V; Sala G; Fracasso G; Ceci P
    J Exp Clin Cancer Res; 2021 Feb; 40(1):63. PubMed ID: 33568214
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Protein Encapsulation of Experimental Anticancer Agents 5F 203 and Phortress: Towards Precision Drug Delivery.
    Breen AF; Scurr D; Cassioli ML; Wells G; Thomas NR; Zhang J; Turyanska L; Bradshaw TD
    Int J Nanomedicine; 2019; 14():9525-9534. PubMed ID: 31824148
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Advancement of the study on iron metabolism and regulation in tumor cells.
    Wang SJ; Gao C; Chen BA
    Chin J Cancer; 2010 Apr; 29(4):451-5. PubMed ID: 20346225
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Metabolic syndrome components and colorectal adenoma in the CLUE II cohort.
    Tsilidis KK; Brancati FL; Pollak MN; Rifai N; Clipp SL; Hoffman-Bolton J; Helzlsouer KJ; Platz EA
    Cancer Causes Control; 2010 Jan; 21(1):1-10. PubMed ID: 19774471
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Starlike vs. classic macromolecular prodrugs: two different antibody-targeted HPMA copolymers of doxorubicin studied in vitro and in vivo as potential anticancer drugs.
    Jelínková M; Strohalm J; Etrych T; Ulbrich K; Ríhová B
    Pharm Res; 2003 Oct; 20(10):1558-64. PubMed ID: 14620507
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Differences in the intracellular fate of free and polymer-bound doxorubicin.
    Hovorka O; St'astný M; Etrych T; Subr V; Strohalm J; Ulbrich K; Ríhová B
    J Control Release; 2002 Apr; 80(1-3):101-17. PubMed ID: 11943391
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Site-specific expression of transferrin receptor by human colon cancer cells directly correlates with eradication by antitransferrin recombinant immunotoxin.
    Shinohara H; Fan D; Ozawa S; Yano S; Van Arsdell M; Viner JL; Beers R; Pastan I; Fidler IJ
    Int J Oncol; 2000 Oct; 17(4):643-51. PubMed ID: 10995873
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A phase II study of advanced colorectal cancer patients treated with combination 5-fluorouracil plus leucovorin and subcutaneous interleukin-2 plus alpha interferon.
    Ridolfi R; Maltoni R; Riccobon A; Flamini E; Fedriga R; Milandri C; Pezzi L; Velotti F; Santoni A; Amadori D
    J Chemother; 1994 Aug; 6(4):265-71. PubMed ID: 7830105
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.